Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
- PMID: 8892715
Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group
Abstract
Objective: To test the hypothesis that bone mineral density (BMD) is associated with the risk of developing breast cancer in older women.
Design: Prospective cohort study with mean (SD) follow-up of 3.2 (1.6) years.
Setting: Four clinical centers, one each located in the following areas: Baltimore, Md; Minneapolis, Minn; Portland, Ore; and the Monongahela Valley in Pennsylvania.
Participants: A total of 6854 nonblack women who were 65 years of age or older and enrolled in the Study of Osteoporotic Fractures.
Measurements: Radius and calcaneus BMD by single photon absorptiometry at baseline; hip and spine BMD by dual-energy x-ray absorptiometry 2 years later.
Main outcome measure: Breast cancer confirmed by medical record review.
Results: A total of 97 women developed breast cancer. In the multivariate model, adjusting for age, the degree of obesity, and other important covariates, the risk of breast cancer was about 30% to 50% higher per 1 SD increase in BMD (relative risk, distal radius BMD=1.50; 95% confidence interval, 1.16-1.95). The age-adjusted incidence rate of breast cancer per 1000 person-years among women in the lowest quartile of distal radius BMD was 2.46, compared with 5.99 among women with the highest BMD. Women with BMD above the 25th percentile were at 2.0 to 2.5 times increased risk of breast cancer compared with women below the 25th percentile. Results were consistent across all BMD sites.
Conclusions: Bone mineral density predicts the risk of breast cancer in older women. The magnitude of the association is similar to that observed between BMD and all fractures. Our findings suggest a link between 2 of the most common conditions affecting a woman's health. Identifying a common denominator for these conditions should substantially improve our understanding of their etiology and prevention.
Comment in
-
Boning up on estrogen: new options, new concerns.JAMA. 1996 Nov 6;276(17):1430-2. JAMA. 1996. PMID: 8892721 No abstract available.
-
Estrogen replacement therapy: new options, continuing concerns.JAMA. 1997 May 21;277(19):1515; author reply 1516-7. doi: 10.1001/jama.1997.03540430027016. JAMA. 1997. PMID: 9153360 No abstract available.
Similar articles
-
Is tubal ligation a risk factor for low bone density and increased risk of fracture?Am J Obstet Gynecol. 1995 Jan;172(1 Pt 1):101-5. doi: 10.1016/0002-9378(95)90092-6. Am J Obstet Gynecol. 1995. PMID: 7847513
-
Appendicular bone density and age predict hip fracture in women. The Study of Osteoporotic Fractures Research Group.JAMA. 1990 Feb 2;263(5):665-8. JAMA. 1990. PMID: 2404146 Clinical Trial.
-
Association between bone mineral density and cognitive decline in older women.J Am Geriatr Soc. 1999 Oct;47(10):1176-82. doi: 10.1111/j.1532-5415.1999.tb05196.x. J Am Geriatr Soc. 1999. PMID: 10522949
-
Systematic review with meta-analysis: non-alcoholic fatty liver disease is associated with a history of osteoporotic fractures but not with low bone mineral density.Aliment Pharmacol Ther. 2019 Feb;49(4):375-388. doi: 10.1111/apt.15087. Epub 2019 Jan 1. Aliment Pharmacol Ther. 2019. PMID: 30600540
-
Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research.J Bone Metab. 2015 Nov;22(4):175-81. doi: 10.11005/jbm.2015.22.4.175. Epub 2015 Nov 30. J Bone Metab. 2015. PMID: 26713308 Free PMC article. Review.
Cited by
-
Cost effectiveness of raloxifene in the treatment of osteoporosis in Sweden: an economic evaluation based on the MORE study.Pharmacoeconomics. 2004;22(17):1153-65. doi: 10.2165/00019053-200422170-00005. Pharmacoeconomics. 2004. PMID: 15612833
-
Chemically induced carcinogenesis in rodent models of aging: assessing organismal resilience to genotoxic stressors in geroscience research.Geroscience. 2019 Apr;41(2):209-227. doi: 10.1007/s11357-019-00064-4. Epub 2019 Apr 29. Geroscience. 2019. PMID: 31037472 Free PMC article. Review.
-
Fracture risk increases after diagnosis of breast or other cancers in postmenopausal women: results from the Women's Health Initiative.Osteoporos Int. 2009 Apr;20(4):527-36. doi: 10.1007/s00198-008-0721-0. Epub 2008 Sep 3. Osteoporos Int. 2009. PMID: 18766294 Free PMC article.
-
Tibolone increases bone mineral density but also relapse in breast cancer survivors: LIBERATE trial bone substudy.Breast Cancer Res. 2012 Jan 17;14(1):R13. doi: 10.1186/bcr3097. Breast Cancer Res. 2012. PMID: 22251615 Free PMC article. Clinical Trial.
-
Skeletal complications of breast cancer therapies.Clin Cancer Res. 2006 Oct 15;12(20 Pt 2):6309s-6314s. doi: 10.1158/1078-0432.CCR-06-0652. Clin Cancer Res. 2006. PMID: 17062720 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical